Home » Newsletters » BioWorld Science

BioWorld Science

June 6, 2002

View Archived Issues

HIV integrase inhibitors in early development at Merck & Co.

Delta opioid ligands reported in GSK patents

GlaxoSmithKline holds patent covering novel antibacterial mutilins

Novel MRI agents for the diagnosis of Alzheimer's disease

Substance P antagonists in the Tanabe Seiyaku pipeline

Lilly Icos presents novel phosphodiesterase inhibitors

New antidepressant disclosed in DOV patent

Intranasal and oral MOL-6131 reduces antigen-induced airways inflammation

Arrest of type 1 diabetes achieved with short-term use of antibody

Naples presentations include new clinical data for ciclesonide in asthma patients

Some clinical benefit seen in patients with MCA stenosis treated with statin

ABT-627 prevents increases in VEGF expression and neovascularization in hypercholesterolemia

Valganciclovir is safe, effective as CMV prophylaxis in kidney and pancreas-kidney transplantation

KW-7158 depresses bladder hyperactivity through afferent pathways

A possible role for the nicotinic agonist epibatidine in neurogenic voiding dysfunction

IPD-1151T may be preferable to other drugs in the treatment of interstitial cystitis

Rho kinase inhibitor attenuates hypoxia-induced pulmonary hypertension in mice

Finalization of phase III protocol for Xyotax in NSCLC and ovarian cancer

MIV-310 produces reduction in viral load in multidrug-resistant HIV patients

Neulasta recommended for approval in E.U. for reduction of chemotherapy-induced neutropenia

Pharmion acquires Refludan rights outside North America

Albany enters natural product drug discovery collaboration with Genzyme

Virulizin granted fast track designation in pancreatic cancer

Lundbeck licenses Cipralex to Mochida in Japan

Launch commences for Avinza, a modified-release formulation of morphine

MX-1094 enters phase I trial in arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...